NCT06797466 Three Dimensional Virtual Reconstruction (3D) in Percutaneous Nephrolithotomy
| NCT ID | NCT06797466 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Adiyaman University |
| Condition | PNL |
| Study Type | INTERVENTIONAL |
| Enrollment | 100 participants |
| Start Date | 2025-01-21 |
| Primary Completion | 2025-01-21 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 100 participants in total. It began in 2025-01-21 with a primary completion date of 2025-01-21.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of our study is to investigate the effect of 3D imaging technique on the PCNL learning curve in specialist training.
Eligibility Criteria
Inclusion Criteria: * Patients with kidney stones larger than 2 cm and those with PCNL indication. Exclusion Criteria: * Patients with missing CT images, missing clinical information, or inaccessible
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06797466 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying PNL. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06797466 currently recruiting?
Yes, NCT06797466 is actively recruiting participants. Contact the research team at bedreddin84@windowslive.com for enrollment information.
Where is the NCT06797466 trial being conducted?
This trial is being conducted at Adıyaman, Turkey (Türkiye).
Who is sponsoring the NCT06797466 clinical trial?
NCT06797466 is sponsored by Adiyaman University. The trial plans to enroll 100 participants.